It’s been nearly two months since Novavax submitted a emergency use authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for Nuvaxovid to be used as a booster.
Amazon, CVS and Walmart have big healthcare ambitions. But critics say the healthcare system is far too complex for these retailers to figure out. How will this high-stakes game end?
The National Foundation for Infectious Diseases (NFID) survey also revealed the reasons why over half of the respondents won’t be getting vaccinated against influenza.